Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)
Melanoma Matters

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

December 29, 202537 min

Summary So many shoutouts in this episode of Melanoma Matters! Sapna and James engage in a lively discussion about MEK inhibitors as monotherapy treatment. They explore the METRIC, NEMO, and pimasertib trials, and discuss side effects associated with this class of therapy. Sapna clears her own confusion regarding the PDUFA date for the NEMO study, and James objects to the way the NEMO abbreviation was derived. Keywords targeted therapy, MEK inhibitors, METRIC, NEMO, pimasertib, NRAS, BRAF, melanoma, oncology, side effects, clinical trials...

Play episode

No transcript for this episode yet

You can still listen to it in the player. On episodes with a transcript, you can tap any word to see its meaning.